Liver imaging study using new biomarkers
Part of Digestive system clinical trials.
This study tests whether a new type of MRI scan can better detect and measure liver disease, including fatty liver and scarring, compared to standard CT scans. If you have chronic liver disease, this study may help improve how we diagnose and track it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a scheduled CT scan that looks at your liver (with or without contrast dye)
- You are able to have an MRI scan (no metal implants, claustrophobia, etc.)
- You have a long-term liver condition, like fatty liver disease or liver scarring (fibrosis)
- You can understand and agree to the study procedures (give informed consent)
- Your body mass index (BMI) is under 45 (due to MRI machine size limits)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new ultrasound device that uses sound waves to measure fat in the liver without needles or surgery. It is for people with a type of fatty liver disease called MASLD or MASH, who are already getting an MRI to check their liver.
This study tests a new ultrasound method to classify fatty liver disease, which might offer a safer and cheaper alternative to MRI. It compares ultrasound results with MRI in healthy people and those with liver disease to see if it can accurately measure liver fat and scarring.
This study tests whether a new type of PET/CT scan can measure liver scarring (fibrosis) in people with fatty liver disease. It might help doctors check liver damage without needing repeated biopsies.
This study uses a new MRI technique to measure how metabolic fatty liver disease affects your body and to track your health over time. It aims to improve understanding of the condition and guide treatment.
This study tests a new type of MRI that can look at the liver in more detail. It compares images from people with liver cancer and healthy people to see if it can help doctors better understand or detect the disease.
This study tests whether a combined PET/MRI scan can better find and see liver tumors or cancer that has spread to the liver. If you are eligible, you will get this special imaging test, which may help doctors diagnose and plan your treatment more accurately.
Hear when a new Fatty Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.